Effective vascular graft mimics natural artery.

In their search for an effective vascular graft to replace a segment of a natural, biological blood vessel, a team of scientists in New Hampshire, USA, has designed a device that mimics the structure of the natural artery (US Patent 6 042 666).

The implantable prosthesis is formed from

layers or tubes of material. It is made by radially nesting a first, second and third layer of material, either as tubes, wound sheets or a wrap. These are then heated to make them coalesce into a continuous wall body. Through the thickness, each region retains the structure of the starting material. The entire structure is made from polytetrafluoroethylene (PTFE) or PTFE with another fluoropolymer.

Native arteries and veins have a common pattern of organization made up of three layers: an internal intima is surrounded by a media and then an external adventitia. Each of these layers has a predominant structure and cell type. The walls of arteries are built of elastin, collagen, a non-fibrous glucosaminoglycan-rich matrix and smooth muscle cells. The microscopic structure of the artery wall correlates with the function of the various wall-layers and components.

Studies seem to show that there is a net transport of macromolecules across the arterial wall, say the scientists. They argue there is a need for an in vivo implantable material device, and in particular a vascular graft, which is formed as a lamellate structure that mimics the natural artery with differential cross-section permeability acceptable to the surrounding tissue.

The graft they have devised improves surgical handling and has enhanced healing properties because of the arrangement of variable porosity regions of PTFE.

There are a number of vascular grafts that are stronger, the scientists admit, but these do not generally have the differential permeability necessary for enhanced healing and tissue ingrowth, nor do they offer improved surgical handling.

The material has other applications, such as heart-valve leaflets, sutures and vascular-access devices. It can also be used for patches or supports for tissue repair or reinforcement.

For further information, contact: patent assignee, Atrium Medical Corp, 5 Wentworth Drive, Hudson, NH 03051-4929, USA; tel: +1-603-880-1433.

Related Articles

  • Datascope wins CE mark for anti-microbial vascular graft.
  • An anti-microbial vascular graft that makes use of the anti-infective properties of silver has won the CE mark, allowing its US manufacturer InterVascular Inc to begin commercial sale of the product throughout Europe. The graft, the InterGard(r) Silver anti-microbial vascular ......
  • Easystand[R] Magician EI[R]. (new products).
  • The EasyStand Magician EI is a fully adjustable standing aid that can be comfortably positioned anywhere between sitting and standing. It provides a wrap-around seat and back support that conform to the child. The Magician EI also comes with side ......
  • Lessons From the Intersexed.
  • Lessons From the Intersexed. By Suzanne J. Kessler. New Brunswick, NJ: Rutgers University Press, 1998, X + 193 pages. Paper, $18.00. Lessons From the Intersexed is a thorough critique of medical and surgical treatment of intersexuality (hermaphroditism). A psychologist at ......
  • Animal submucosal tissue proves useful for myocardial grafts.
  • Tissue grafts made from the submucosal tissue of a warm-blooded vertebrate have the potential to promote growth of endogenous cardiac tissues in vivo, claim a group of US inventors. They argue that it is already known that tissue grafts can ......
  • Tissuemed gains worldwide protection for tissue technology.
  • The US Patent and Trademark Office's recent award of a patent to UK tissue engineering company, Tissuemed, effectively gives the company worldwide protection for its tissue technology. The US patent (No 6 197 296) Tissue Equivalents follows the granting of ......
  • Coating process offers range of advantages.
  • A method of binding a bioactive material onto the surface of a biocompatible polymeric substrate has been developed that offers a range of advantages over existing methods, claims USA-based inventor Birendra Patnaik. Binding of an anti-infection agent to the surface ......
  • US approval for vascular graft.
  • A vascular graft that is able to offer both strength and to reduce the weeping often seen with traditional bypass grafts has gained US Food and Drug Administration approval. Trademarked Flixene, the graft was developed by Atrium Medical Corp, USA....
  • Tissue Science Labs reports research progress, gains boost for key product Permacol.
  • Operational changes may be paying off for the UK company Tissue Science Laboratories plc (TSL). In a recent trading statement about results for 2006, the company noted several areas of commercial and research success, although the expected net loss for ......
  • Cerenis Therapeutics Completes $53.5 Million Equity Round.
  • SciTech21-13 November 2006-Cerenis Therapeutics Completes $53.5 Million Equity Round(C)2006 JeraOne - http://www.jeraone.com Cerenis Therapeutics SA, a privately held pharmaceutical research and development company, today announced the closing of a $53.5 million equity financing round in one of the largest private ......
  • BIOPROSTHESES: Plasma treatment may be useful for small-calibre hybrid vascular grafts
  • Small-calibre synthetic vascular grafts usually fail because of thrombus formation, in the short term, and intimal hyperplasia caused by a mismatch between the graft and the host tissue, in the longer term, say scientists based in Japan. But they may ......
  • Organogenesis creates more capital.
  • Organogenesis Inc is selling US$10 million in equity to Novartis Pharma AG. In this way, the US tissue engineering company hopes to add to its general working capital. Earlier this year, Organogenesis said it signed an amended agreement with Novartis ......
  • Charles Sandison: Yvon Lambert.
  • It has always seemed that more artists should have followed Jenny Holzer's lead, illuminating and animating words in order to address the complex variety of ways in which kinetic texts address us in everyday life. Charles Sandison is one of ......
  • New toxin detector has applications in fighting bioterrorism.
  • Department of Energy researchers at the Los Alamos National Laboratory have developed a technique for detecting the toxin that causes cholera. The technique should work equally well in detecting other protein-based toxins, including toxins that might be used in bioterrorism ......
  • Fish Oil Reduces Clotting in Dialysis.
  • Fish oil supplements dramatically can reduce clotting, a common and serious complication for patients with kidney failure who rely on dialysis treatments, notes Paul Schmitz, associate professor of internal medicine in the Division of Nephrology, Saint Louis (Mo.) University School ......
  • Thermo Cardiosystems and Thoratec merge.
  • ThermoCardiosystems Inc, a public subsidiary of Thermo Electron Co, is merging with Thoratec Laboratories Corp. The new firm will be called Thoratec Corp. Under the terms of the agreement, each issued and outstanding share of ThermoCardio- systems stock will be ......

Related Topics